Send feedback

WEE2 p.Ala264=

c.792A>G · rs6967301 · VCV3059633

Benign No assertion criteria
Classification
Benign
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Common
common (popmax 75%, afr) — too common for a highly-penetrant pathogenic allele
Conditions
1
WEE2-related disorder

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -5.4GERP -9.5
Overall
CADD0.191PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 75% African / African-American · 56,258/74,968 alleles
Filtering AF 74.5% ClinGen BA1/BS1 input FAF95, joint · FAF99 74.3%
Overall 52% 839,272/1,613,268 alleles · common exomes 752,405/1,461,124 · genomes 86,867/152,144 · joint denominator
Ancestry group Frequency 1 in
African / African-Americangrpmax 75% 1
South Asian 60.3% 2
Amishnot grpmax-eligible 59.5% 2
Middle Eastern 57.2% 2
Ashkenazi Jewishnot grpmax-eligible 56.6% 2
Finnishnot grpmax-eligible 53.2% 2
Remaining individualsnot grpmax-eligible 51.8% 2
Admixed American 50.6% 2
European (non-Finnish) 50.5% 2
East Asian 32.4% 3

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
WEE2
Protein
p.Ala264=
Coding
c.792A>G
MANE Select
NM_001105558
dbSNP
rs6967301
Type
single nucleotide variant
Location
chr7:141720968 (GRCh38)
Gene constraint
LOEUF 1.031 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 67.50 · 1 PDB
Residue 264
the protein kinase domain; an α-helix
Full WEE2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

WEE2-related disorder

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/wee2-p-ala264 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown